Correction
for Cohen et al., J Immunol 175 (9) 5799-5808.
The Journal of Immunology, 2006, 177: 5746.
Copyright © 2006 by The American Association of Immunologists, Inc.
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR.
C. J. Cohen,
Z. Zheng,
R. Bray,
Y. Zhao,
L. A. Sherman,
S. A. Rosenberg and
R. A. Morgan
Cohen, C. J., Z. Zheng, R. Bray, Y. Zhao, L. A. Sherman, S. A. Rosenberg, and R. A. Morgan. 2005. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J. Immunol. 175: 5799–5808
.
In Results, under the heading Recognition of tumor cell lines by TCR-transduced PBLs, the third sentence of the first paragraph should reference non-small cell lung cancer, not small cell lung cancer. The corrected sentence is shown below.
HLA-A2 and p53 double-positive tumors, including melanoma, hepatoma, sarcoma, non-small cell lung cancer, and esophageal and breast tumors specifically stimulated TCR-transduced T cells to secrete cytokines IFN-
(Fig. 4) and IL-2 (Fig. 5).
In Figures 4 and 5, the pathology of three cells was incorrectly labeled. In Figure 4, cell line H2228 was identified as small cell lung cancer (SCLC) while the correct pathology is non-small cell lung cancer (NSCLC). In both Figures 4 and 5, the cell line BE-3 was identified as (SCLC) while its correct origin is (Esophagus) and cell line H2087 was identified as (SCLC) while the correct pathology is (NSCLC). None of these changes affect any of the conclusions or interpretations in the paper. The corrected figures are shown below.
